BRPI0924013A2 - método para o exame de câncer - Google Patents

método para o exame de câncer

Info

Publication number
BRPI0924013A2
BRPI0924013A2 BRPI0924013A BRPI0924013A BRPI0924013A2 BR PI0924013 A2 BRPI0924013 A2 BR PI0924013A2 BR PI0924013 A BRPI0924013 A BR PI0924013A BR PI0924013 A BRPI0924013 A BR PI0924013A BR PI0924013 A2 BRPI0924013 A2 BR PI0924013A2
Authority
BR
Brazil
Prior art keywords
cancer screening
cancer
screening
Prior art date
Application number
BRPI0924013A
Other languages
English (en)
Inventor
Hung-Cheng Lai
Original Assignee
Hung-Cheng Lai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hung-Cheng Lai filed Critical Hung-Cheng Lai
Publication of BRPI0924013A2 publication Critical patent/BRPI0924013A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57419Specifically defined cancers of colon
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/164Methylation detection other then bisulfite or methylation sensitive restriction endonucleases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
BRPI0924013A 2009-04-17 2009-04-17 método para o exame de câncer BRPI0924013A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2009/000411 WO2010118559A1 (zh) 2009-04-17 2009-04-17 一种癌症筛检的方法

Publications (1)

Publication Number Publication Date
BRPI0924013A2 true BRPI0924013A2 (pt) 2015-11-24

Family

ID=42982108

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0924013A BRPI0924013A2 (pt) 2009-04-17 2009-04-17 método para o exame de câncer

Country Status (12)

Country Link
EP (1) EP2420578B1 (pt)
JP (1) JP6043185B2 (pt)
KR (2) KR101636596B1 (pt)
AU (1) AU2009344468B2 (pt)
BR (1) BRPI0924013A2 (pt)
CA (1) CA2758437C (pt)
DK (1) DK2420578T3 (pt)
ES (1) ES2638294T3 (pt)
IL (1) IL215669A0 (pt)
NZ (1) NZ595640A (pt)
SG (1) SG175183A1 (pt)
WO (1) WO2010118559A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101385783B1 (ko) * 2012-06-25 2014-04-16 가톨릭대학교 산학협력단 간암 진단 마커 및 치료제로서의 dbc1
JP2016201999A (ja) * 2013-08-26 2016-12-08 北海道公立大学法人 札幌医科大学 大腸癌を検出する方法
EP3344783A4 (en) * 2015-08-31 2019-07-17 The United States Of America As Represented By The Secretary Of The Army PROCESS FOR THE MOLECULAR CHARACTERIZATION OF CERVICAL CELL SAMPLES
JP7299158B2 (ja) * 2017-03-10 2023-06-27 セルフ-スクリーン ベー.フェー. Hpv誘発浸潤がん、非hpv誘発婦人科がん及び肛門性器がん、並びにその高度前駆病変を検出するためのメチル化分類子
CN109468381B (zh) * 2018-11-19 2022-11-25 兰州市第一人民医院 用于宫颈癌筛查的甲基化位点及其检测引物
US11396679B2 (en) 2019-05-31 2022-07-26 Universal Diagnostics, S.L. Detection of colorectal cancer
US11001898B2 (en) 2019-05-31 2021-05-11 Universal Diagnostics, S.L. Detection of colorectal cancer
US11898199B2 (en) 2019-11-11 2024-02-13 Universal Diagnostics, S.A. Detection of colorectal cancer and/or advanced adenomas
GB202009220D0 (en) * 2020-06-17 2020-07-29 Ucl Business Ltd Methods for detecting and predicting cancer
WO2022002424A1 (en) 2020-06-30 2022-01-06 Universal Diagnostics, S.L. Systems and methods for detection of multiple cancer types
CN114561461B (zh) * 2020-11-27 2024-01-30 广州达健生物科技有限公司 用于检测宫颈癌的组合物及其试剂盒和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2294462T5 (es) * 2003-01-29 2015-05-06 Epigenomics Ag Método mejorado para el tratamiento de bisulfito
GB0413688D0 (en) * 2004-06-18 2004-07-21 Novartis Forschungsstiftung Analysis of methylated nucleic acid
WO2007122369A2 (en) * 2006-04-13 2007-11-01 Oncomethylome Sciences Sa Novel tumour suppressor
TW200831900A (en) 2007-01-23 2008-08-01 Hong-Zheng Lai Cancer screen method
US7820386B2 (en) 2007-06-15 2010-10-26 National Defense Medical Center Cancer screening method
CN101250588A (zh) * 2008-04-09 2008-08-27 王道荣 一种利用粪便中sfrp2基因超甲基化筛查大肠癌的方法

Also Published As

Publication number Publication date
AU2009344468A1 (en) 2011-11-03
AU2009344468B2 (en) 2015-02-12
EP2420578B1 (en) 2017-06-14
SG175183A1 (en) 2011-12-29
DK2420578T3 (en) 2017-10-02
KR101530498B1 (ko) 2015-06-19
EP2420578A4 (en) 2012-09-26
ES2638294T3 (es) 2017-10-19
EP2420578A1 (en) 2012-02-22
KR20140017704A (ko) 2014-02-11
IL215669A0 (en) 2012-01-31
WO2010118559A1 (zh) 2010-10-21
KR101636596B1 (ko) 2016-07-11
JP2012523822A (ja) 2012-10-11
NZ595640A (en) 2014-01-31
JP6043185B2 (ja) 2017-02-22
KR20120016201A (ko) 2012-02-23
CA2758437A1 (en) 2010-10-21
CA2758437C (en) 2018-10-09

Similar Documents

Publication Publication Date Title
BRPI0924013A2 (pt) método para o exame de câncer
BRPI1010766A2 (pt) processo para rebaudiosídeo d
BRPI1006075A2 (pt) biomarcadores de cancer
BR112012002746A2 (pt) método para produção de copolímero
BRPI0918550A2 (pt) projeto de sinal de referência para lte avancada
BR112012010958A2 (pt) método para intensificação de feixe
EP2423323A4 (en) METHOD OF TUMOR ASSESSMENT
BRPI1008672A2 (pt) método para tratar um furo de poço.
BR112012002335A2 (pt) pigmento composto e método para preparação do mesmo
BRPI1012813A2 (pt) aparelho e método para modelar projetos de poço e desempenho de poço
BRPI1009549A2 (pt) aparelho para fabricação de estrutura de aeronave
BRPI1013618A2 (pt) pirimidinas substituídas para o tratamento de câncer
HK1173219A1 (en) Screening method utilizing thalidomide-targeting factor
BRPI0922490A2 (pt) Método para produção de beta-santaleno
BRPI1007459A2 (pt) método para produção de manômeros olefínicos
BRPI1011791A2 (pt) montagem para perfuração de fundo de poço
BRPI1009919A2 (pt) combinações de pentamidina para tratamento de câncer.
BRPI0814406A2 (pt) Método para produzir dimetacrilato de etileno glicol
BRPI1011731A2 (pt) dispositivo para produzir fechos
BRPI0818674A2 (pt) Método para produção de anticorpos
BRPI1007320A2 (pt) Método para preparar nitrotetrazolato de cobre
BRPI1012529A2 (pt) método para produção de sínter
BRPI0923370A2 (pt) Método para produção de titanossilicato
BRPI0918744A2 (pt) Metodo para produção de açúcar
BRPI0918508A2 (pt) orto-aminoanilidas para o tratamento de câncer

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: NATIONAL DEFENSE MEDICAL CENTER (TW)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements